At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03696 INSILICO
Not Yet Opened 10-22 16:08:35
36.000
-2.600
-6.74%
High38.820
Low35.600
Vol15.14M
Open38.420
D1 Closing38.600
Amplitude8.34%
Mkt Cap21.06B
Tradable Cap21.06B
Total Shares585.00M
T/O550.19M
T/O Rate2.59%
Tradable Shares585.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Movement Alert｜INSILICO Falls 5.44% in Regular Trading, UBS Downgrades Rating to Neutral
Hong Kong Stock Announcements: Dongshan Precision Launches IPO, Li Auto Introduces External Equity Financing for Mahexin Technology via Capital Subscription Agreement
InSilico Medicine Cayman TopCo is a company principally engaged in the artificial intelligence (AI)-driven drug discovery and pipeline development business. The Company mainly self-develops drug candidates, co-develops and partially retains certain intellectual property (IP) rights for out-licensed drugs as well as collaborates with other pharmaceutical companies without retaining any IP rights. The Company generated several clinical or IND-enabling stage assets using its own AI platform under the name of Pharma.AI. The Company is also engaged in software solutions and other discovery business related to non-pharma sectors.